Peer Comparison Feedback for High Blood Pressure
Trial Summary
What is the purpose of this trial?
As part of a roll out of new payment model for physicians based on hypertension control, the investigators will evaluate a monthly peer comparison message to Primary Care Providers at Penn Medicine Lancaster to see whether provider engagement with patients' overall hypertension management increases, as measured by new or increasing doses of anti-hypertensive medications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on evaluating doctors' management of high blood pressure, so it's best to ask the trial coordinators for more details.
What data supports the effectiveness of the treatment Peer Comparison Message for high blood pressure?
Research shows that providing peer comparison feedback to physicians can improve the management of high blood pressure, as seen in a study where uncontrolled hypertension decreased from 46.8% to 34.3% after implementing peer review and feedback. This suggests that peer comparison messages can be effective in improving blood pressure control.12345
Is Peer Comparison Feedback for High Blood Pressure safe for humans?
How does the treatment 'Peer Comparison Feedback' for high blood pressure differ from other treatments?
Peer Comparison Feedback is unique because it focuses on modifying physician behavior through performance report cards, rather than directly treating the patient with medication or lifestyle changes. This approach aims to improve clinical performance and patient outcomes by providing physicians with feedback on their performance compared to their peers.13111213
Research Team
Shivan Mehta, MD,MBA,MSHP
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for Primary Care Providers at Penn Medicine Lancaster with at least 30 patients who have high blood pressure. These patients must be aged 18-85 and have had a diagnosis of hypertension in the last two years. Excluded are providers with fewer than 30 such patients, those caring for patients with end stage renal disease, recent pregnancy, or indicators of end-of-life care.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Primary Care Providers receive monthly peer comparison messages to improve hypertension management
Control
Primary Care Providers continue with usual care and access hypertension control rates via EPIC dashboard
Follow-up
Participants are monitored for changes in hypertensive medication prescriptions and hypertension control percentage
Treatment Details
Interventions
- Peer Comparison Message
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor